Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-α
- 29 August 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 310 (2-3) , 209-216
- https://doi.org/10.1016/0014-2999(96)00272-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- 2-Chloroadenosine Inhibits the MHC-Unrestricted Cytolytic Activity of Anti-CD3-Activated Killer Cells: Evidence for the Involvement of a Non-A1/A2 Cell-Surface Adenosine ReceptorCellular Immunology, 1994
- Inhibition of human monocyte TNF production by adenosine receptor agonistsLife Sciences, 1993
- Role of protein kinase a in LPS-induced activation of NF-κB proteins of a mouse macrophage-like cell line, J774Cellular Signalling, 1993
- Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtypeMolecular Endocrinology, 1992
- Physiological and pharmacological properties of adenosine: Therapeutic implicationsLife Sciences, 1991
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.The Journal of Experimental Medicine, 1990
- ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLSJournal of Neurochemistry, 1979
- Platelet aggregation inhibitors. 4. N6-Substituted adenosinesJournal of Medicinal Chemistry, 1973